Literature DB >> 24970952

Cardiometabolic Health in Bipolar Disorder.

David E Kemp1, Jinbo Fan2.   

Abstract

Entities:  

Year:  2012        PMID： 24970952      PMCID： PMC4067699          DOI： 10.3928/00485713-20120507-05

Source DB:  PubMed          Journal:  Psychiatr Ann        ISSN： 0048-5713


× No keyword cloud information.
  46 in total

Review 1.  The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.

Authors:  Roger S McIntyre; Mohammad Alsuwaidan; Benjamin I Goldstein; Valerie H Taylor; Ayal Schaffer; Serge Beaulieu; David E Kemp
Journal:  Ann Clin Psychiatry       Date:  2012-02       Impact factor: 1.567

2.  Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey.

Authors:  Benjamin G Druss; Liping Zhao; Silke Von Esenwein; Elaine H Morrato; Steven C Marcus
Journal:  Med Care       Date:  2011-06       Impact factor: 2.983

Review 3.  Bipolar disorder and metabolic syndrome: an international perspective.

Authors:  Roger S McIntyre; Marlon Danilewitz; Samantha S Liauw; David E Kemp; Ha T T Nguyen; Linda S Kahn; Aaron Kucyi; Joanna K Soczynska; Hanna O Woldeyohannes; Angela Lachowski; Byungsu Kim; Jay Nathanson; Mohammad Alsuwaidan; Valerie H Taylor
Journal:  J Affect Disord       Date:  2010-06-12       Impact factor: 4.839

4.  The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.

Authors:  Michael Berk; Olivia Dean; Sue M Cotton; Clarissa S Gama; Flavio Kapczinski; Brisa S Fernandes; Kristy Kohlmann; Susan Jeavons; Karen Hewitt; Christine Allwang; Heidi Cobb; Ashley I Bush; Ian Schapkaitz; Seetal Dodd; Gin S Malhi
Journal:  J Affect Disord       Date:  2011-06-29       Impact factor: 4.839

Review 5.  Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.

Authors:  Ewan C McNay; Andrew K Recknagel
Journal:  Neurobiol Learn Mem       Date:  2011-08-30       Impact factor: 2.877

6.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

7.  Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Brian E Perron; Matthew O Howard; Jenna K Nienhuis; Mark S Bauer; Amanda Toler Woodward; Amy M Kilbourne
Journal:  J Clin Psychiatry       Date:  2009-10       Impact factor: 4.384

Review 8.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.

Authors:  Benjamin I Goldstein; David E Kemp; Joanna K Soczynska; Roger S McIntyre
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

Review 9.  Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism.

Authors:  Jinbo Fan; Pamela Sklar
Journal:  Novartis Found Symp       Date:  2008

10.  Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

Authors:  George J Francis; Jose A Martinez; Wei Q Liu; Kevin Xu; Amit Ayer; Jared Fine; Ursula I Tuor; Gordon Glazner; Leah R Hanson; William H Frey; Cory Toth
Journal:  Brain       Date:  2008-11-16       Impact factor: 13.501
View more
  1 in total

1.  PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.

Authors:  David E Kemp; Martha Schinagle; Keming Gao; Carla Conroy; Stephen J Ganocy; Faramarz Ismail-Beigi; Joseph R Calabrese
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.